Pre-order Enquiry
Request Free Sample
Global Clinical Trial Management Systems (CTMS) Market Size, Status and Forecast 2019-2025
SKU ID : QYR-14199009 | Publishing Date : 13-May-2019 | No. of pages : 98
Request Sample
Request Customization
Check Discounts
Clinical Trial Management System (CTMS) is a software system used by biotechnology and pharmaceutical industries to manage clinical trials in clinical research. The system maintains and manages planning, performing and reporting functions, along with participant contact information, tracking deadlines and milestones.
North America led the global market in 2017 and accounted for around 51% of the overall market. This growth was attributed to the availability of favorable regulatory policies and higher investments by the pharma companies. Asia Pacific is expected to be the fastest-growing region during the forecast period Due to increasing costs and time spent on clinical trials and outsourcing of clinical trials in the region. Asian countries offer a less expensive and less time-consuming process for clinical trials, thereby boosting the CTMS market in the region.
In 2018, the global Clinical Trial Management Systems (CTMS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Clinical Trial Management Systems (CTMS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trial Management Systems (CTMS) development in United States, Europe and China.
The key players covered in this study
Oracle Corporation
Merge Healthcare Incorporated
Medidata Solutions
PAREXEL International Corporation
BioClinica
MedNet Solutions
Bio-Optronics
DSG
Forte Research Systems
ERT
DATATRAK International
VEEVA SYSTEMS
Market segment by Type, the product can be split into
Enterprise CTMS
Site CTMS
Market segment by Application, split into
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Medical Device Companies
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Clinical Trial Management Systems (CTMS) status, future forecast, growth opportunity, key market and key players.
To present the Clinical Trial Management Systems (CTMS) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Clinical Trial Management Systems (CTMS) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
North America led the global market in 2017 and accounted for around 51% of the overall market. This growth was attributed to the availability of favorable regulatory policies and higher investments by the pharma companies. Asia Pacific is expected to be the fastest-growing region during the forecast period Due to increasing costs and time spent on clinical trials and outsourcing of clinical trials in the region. Asian countries offer a less expensive and less time-consuming process for clinical trials, thereby boosting the CTMS market in the region.
In 2018, the global Clinical Trial Management Systems (CTMS) market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Clinical Trial Management Systems (CTMS) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Clinical Trial Management Systems (CTMS) development in United States, Europe and China.
The key players covered in this study
Oracle Corporation
Merge Healthcare Incorporated
Medidata Solutions
PAREXEL International Corporation
BioClinica
MedNet Solutions
Bio-Optronics
DSG
Forte Research Systems
ERT
DATATRAK International
VEEVA SYSTEMS
Market segment by Type, the product can be split into
Enterprise CTMS
Site CTMS
Market segment by Application, split into
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations
Medical Device Companies
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Clinical Trial Management Systems (CTMS) status, future forecast, growth opportunity, key market and key players.
To present the Clinical Trial Management Systems (CTMS) development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Clinical Trial Management Systems (CTMS) are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
